Evaluation of the Oncomine Comprehensive Assay v3 and Early Experience with the Oncomine Comprehensive Assay Plus on the Genexus System

Watch a 17-minute webinar presentation by Dr. Bin Wang, a senior hospital scientist with over 27 years of experience in molecular genetics, who discusses the validation process and implementation of targeted panels for cancer genomic variant identification. Learn about the comprehensive validation work performed using Oncomine Comprehensive Assay V3 GX on the Genexus system, including detailed test results showing 97% sensitivity in SNVs, 100% in MNVs and indels, successful detection of CNV and fusion events, and 100% specificity across multiple parameters. Gain insights into how clinical laboratories are implementing regulated targeted panels to improve patient outcomes through cancer genomic testing. PACE continuing education credits are available for registered Labroots members who complete the webinar viewing requirements before March 29, 2025.